Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank80
5Y CAGR+4.0%
Studio
Year-over-Year Change

Income taxes paid or accrued

5Y CAGR
+4.0%/yr
Long-term compound
Percentile
P80
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$315000.00-27.9%
2025$437000.00-79.6%
2024$2.14M-
2023$0.00+100.0%
2022$-110000.00-142.5%
2021$259000.00-
2020$0.00-100.0%
2019$20.04M-
2018$0.00-
2017$0.00-